Received Apr 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37kr7 | IM / LL |
Vaccine experienced a temperature excursion resulting in frozen vaccine making it non-viable for administration.
n/a
Congenital Heart Defect
n/a
n/a